Canada markets closed

Ceapro Inc. (CZO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.7000-0.0200 (-2.78%)
At close: 12:24PM EST
Full screen
Previous Close0.7200
Open0.7000
Bid0.7000 x 0
Ask0.7200 x 0
Day's Range0.7000 - 0.7000
52 Week Range0.4000 - 0.8200
Volume26,500
Avg. Volume22,412
Market Cap54.753M
Beta (5Y Monthly)1.48
PE Ratio (TTM)10.00
EPS (TTM)0.0700
Earnings DateApr 11, 2023 - Apr 17, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

    JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2023 Companies to Watch Event, January 17-19, 2023.

  • GlobeNewswire

    Ceapro to Present at the Virtual Investor 2023 Companies to Watch Event

    Live video webcast on Wednesday, January 18th at 3:00 PM ETEDMONTON, Alberta, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, M.Sc., MBA, President and Chief Executive Officer of Ceapro, will present at the Virtual Investor 2023 Companies to Watch Event on Wedne

  • GlobeNewswire

    Ceapro Announces Grant of Stock Options

    EDMONTON, Alberta, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced the granting of stock options (“options”) to employees, officers and directors of the Company. Options to purchase 740,000 common shares were granted pursuant to the Company’s Stock Option Plan, with an exercise pri